Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,005 public trials 1,840 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia

NCT00458848

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Ospedale Civile Alessandria Alessandria, Italy
  • Ospedale Torrette University Ancona Ancona, Italy
  • Ospedale S. Donato Arezzo, Italy
  • Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli Piceno, Italy
View all 66 locations
View Trial Details
Completed

Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma

NCT01874054

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Pacific Hematology Oncology Associates San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Oncology Institute of Hope & Innovation, The Whittier, California, United States
View all 13 locations
View Trial Details
Completed

A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL)

NCT01456039

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Nagoya Daini Red Cross Hospital Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Ehime University Hospital Tōon, Ehime, Japan
View all 17 locations
View Trial Details
Completed

Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT02142049

Conditions
Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, Hemic and Lymphatic Diseases, +7 more
Locations
  • SITE-1 Duarte, California, United States
  • SITE-2 Los Angeles, California, United States
  • SITE-10 Orange, California, United States
  • SITE-3 Chicago, Illinois, United States
View Trial Details

Related conditions